Retraction Notice to: A Monoclonal Antibody that Targets a NaV1.7 Channel Voltage Sensor for Pain and Itch Relief (Cell (2014) 157(6) (1393–1404), (S0092867414005996), (10.1016/j.cell.2014.03.064));A monoclonal antibody that targets a NaV1.7 channel voltage sensor for pain and itch relief

Cell

Volumn 157, Issue 6, 2014, Pages 1393-1404

  Lee, Jun Ho ^a   Park, Chul Kyu ^a   Chen, Gang ^a   Han, Qingjian ^a   Xie, Rou Gang ^a   Liu, Tong ^a   Ji, Ru Rong ^a   Lee, Seok Yong ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; MONOCLONAL ANTIBODY; SODIUM CHANNEL NAV1.7; SODIUM CHANNEL NAV1.7 MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ACTION POTENTIAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN BINDING; ARTICLE; CHANNEL GATING; CONTROLLED STUDY; HUMAN; HUMAN CELL; INFLAMMATORY PAIN; MOUSE; NERVE CELL; NEUROPATHIC PAIN; NONHUMAN; PRIORITY JOURNAL; PRURITUS; SODIUM CURRENT; SPINAL CORD; SPINAL CORD DORSAL HORN; SYNAPTIC TRANSMISSION;

MUS;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; HEK293 CELLS; HUMANS; INFLAMMATION; MICE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; NAV1.7 VOLTAGE-GATED SODIUM CHANNEL; NEURONS; PAIN; PRURITUS; SEQUENCE ALIGNMENT; SPINAL CORD; SYNAPTIC TRANSMISSION; VOLTAGE-GATED SODIUM CHANNEL BLOCKERS;

EID: 84902215464     PISSN: 00928674     EISSN: 10974172     Source Type: Journal    
DOI: 10.1016/j.cell.2020.06.019     Document Type: Erratum

References (55)

1. T. Akiyama, and E. Carstens Neural processing of itch Neuroscience 250 2013 697 714
2. T. Akiyama, M. Tominaga, K. Takamori, M.I. Carstens, and E. Carstens Roles of glutamate, substance P, and gastrin-releasing peptide as spinal neurotransmitters of histaminergic and nonhistaminergic itch Pain 155 2013 80 92
3. A.A. Alabi, M.I. Bahamonde, H.J. Jung, J.I. Kim, and K.J. Swartz Portability of paddle motif function and pharmacology in voltage sensors Nature 450 2007 370 375
4. C.M. Armstrong, and F. Bezanilla Charge movement associated with the opening and closing of the activation gates of the Na channels J. Gen. Physiol. 63 1974 533 552
5. A. Beck, T. Wurch, C. Bailly, and N. Corvaia Strategies and challenges for the next generation of therapeutic antibodies Nat. Rev. Immunol. 10 2010 345 352
6. J.A. Black, N. Frézel, S.D. Dib-Hajj, and S.G. Waxman Expression of Nav1.7 in DRG neurons extends from peripheral terminals in the skin to central preterminal branches and terminals in the dorsal horn Mol. Pain 8 2012 82
7. R. Bolognesi, D. Tsialtas, P. Vasini, M. Conti, and C. Manca Abnormal ventricular repolarization mimicking myocardial infarction after heterocyclic antidepressant overdose Am. J. Cardiol. 79 1997 242 245
8. J.M. Casadei, R.D. Gordon, L.A. Lampson, D.L. Schotland, and R.L. Barchi Monoclonal antibodies against the voltage-sensitive Na+ channel from mammalian skeletal muscle Proc. Natl. Acad. Sci. USA 81 1984 6227 6231
9. S. Cestèle, Y. Qu, J.C. Rogers, H. Rochat, T. Scheuer, and W.A. Catterall Voltage sensor-trapping: enhanced activation of sodium channels by beta-scorpion toxin bound to the S3-S4 loop in domain II Neuron 21 1998 919 931
10. A. Cha, P.C. Ruben, A.L. George Jr., E. Fujimoto, and F. Bezanilla Voltage sensors in domains III and IV, but not I and II, are immobilized by Na+ channel fast inactivation Neuron 22 1999 73 87
11. A.C. Chan, and P.J. Carter Therapeutic antibodies for autoimmunity and inflammation Nat. Rev. Immunol. 10 2010 301 316
12. J.J. Cox, F. Reimann, A.K. Nicholas, G. Thornton, E. Roberts, K. Springell, G. Karbani, H. Jafri, J. Mannan, and Y. Raashid et al. An SCN9A channelopathy causes congenital inability to experience pain Nature 444 2006 894 898
13. N.B. Cronin, A. O'Reilly, H. Duclohier, and B.A. Wallace Binding of the anticonvulsant drug lamotrigine and the neurotoxin batrachotoxin to voltage-gated sodium channels induces conformational changes associated with block and steady-state activation J. Biol. Chem. 278 2003 10675 10682
14. J.P. Drenth, W.H. Finley, G.J. Breedveld, L. Testers, J.J. Michiels, G. Guillet, A. Taieb, R.L. Kirby, and P. Heutink The primary erythermalgia- susceptibility gene is located on chromosome 2q31-32 Am. J. Hum. Genet. 68 2001 1277 1282
15. D.S. Echt, P.R. Liebson, L.B. Mitchell, R.W. Peters, D. Obias-Manno, A.H. Barker, D. Arensberg, A. Baker, L. Friedman, and H.L. Greene et al. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial N. Engl. J. Med. 324 1991 781 788
16. N. Eijkelkamp, J.E. Linley, M.D. Baker, M.S. Minett, R. Cregg, R. Werdehausen, F. Rugiero, and J.N. Wood Neurological perspectives on voltage-gated sodium channels Brain 135 2012 2585 2612
17. S. England, and M.J. de Groot Subtype-selective targeting of voltage-gated sodium channels Br. J. Pharmacol. 158 2009 1413 1425
18. A. Escayg, and A.L. Goldin Sodium channel SCN1A and epilepsy: mutations and mechanisms Epilepsia 51 2010 1650 1658
19. C.R. Fertleman, M.D. Baker, K.A. Parker, S. Moffatt, F.V. Elmslie, B. Abrahamsen, J. Ostman, N. Klugbauer, J.N. Wood, R.M. Gardiner, and M. Rees SCN9A mutations in paroxysmal extreme pain disorder: allelic variants underlie distinct channel defects and phenotypes Neuron 52 2006 767 774
20. L. Han, C. Ma, Q. Liu, H.J. Weng, Y. Cui, Z. Tang, Y. Kim, H. Nie, L. Qu, and K.N. Patel et al. A subpopulation of nociceptors specifically linked to itch Nat. Neurosci. 16 2013 174 182
21. J.L. Hylden, and G.L. Wilcox Intrathecal morphine in mice: a new technique Eur. J. Pharmacol. 67 1980 313 316
22. Y. Jiang, A. Lee, J. Chen, V. Ruta, M. Cadene, B.T. Chait, and R. MacKinnon X-ray structure of a voltage-dependent K+ channel Nature 423 2003 33 41
23. Y. Jiang, V. Ruta, J. Chen, A. Lee, and R. MacKinnon The principle of gating charge movement in a voltage-dependent K+ channel Nature 423 2003 42 48
24. K. Jurkat-Rott, B. Holzherr, M. Fauler, and F. Lehmann-Horn Sodium channelopathies of skeletal muscle result from gain or loss of function Pflugers Arch. 460 2010 239 248
25. K. Koga, T. Chen, X.Y. Li, G. Descalzi, J. Ling, J. Gu, and M. Zhuo Glutamate acts as a neurotransmitter for gastrin releasing peptide-sensitive and insensitive itch-related synaptic transmission in mammalian spinal cord Mol. Pain 7 2011 47
26. S.Y. Lee, and R. MacKinnon A membrane-access mechanism of ion channel inhibition by voltage sensor toxins from spider venom Nature 430 2004 232 235
27. Y.J. Liao, P. Safa, Y.R. Chen, R.A. Sobel, E.S. Boyden, and R.W. Tsien Anti-Ca2+ channel antibody attenuates Ca2+ currents and mimics cerebellar ataxia in vivo Proc. Natl. Acad. Sci. USA 105 2008 2705 2710
28. T. Liu, and R.R. Ji New insights into the mechanisms of itch: are pain and itch controlled by distinct mechanisms? Pflugers Arch. 465 2013 1671 1685
29. Y. Liu, O. Abdel Samad, L. Zhang, B. Duan, Q. Tong, C. Lopes, R.R. Ji, B.B. Lowell, and Q. Ma VGLUT2-dependent glutamate release from nociceptors is required to sense pain and suppress itch Neuron 68 2010 543 556
30. T. Liu, T. Berta, Z.Z. Xu, C.K. Park, L. Zhang, N. Lü, Q. Liu, Y. Liu, Y.J. Gao, and Y.C. Liu et al. TLR3 deficiency impairs spinal cord synaptic transmission, central sensitization, and pruritus in mice J. Clin. Invest. 122 2012 2195 2207
31. Q. Ma Labeled lines meet and talk: population coding of somatic sensations J. Clin. Invest. 120 2010 3773 3778
32. K. McCormack, S. Santos, M.L. Chapman, D.S. Krafte, B.E. Marron, C.W. West, M.J. Krambis, B.M. Antonio, S.G. Zellmer, and D. Printzenhoff et al. Voltage sensor interaction site for selective small molecule inhibitors of voltage-gated sodium channels Proc. Natl. Acad. Sci. USA 110 2013 E2724 E2732
33. M.S. Minett, M.A. Nassar, A.K. Clark, G. Passmore, A.H. Dickenson, F. Wang, M. Malcangio, and J.N. Wood Distinct Nav1.7-dependent pain sensations require different sets of sensory and sympathetic neurons Nat. Commun. 3 2012 791
34. S.K. Mishra, and M.A. Hoon The cells and circuitry for itch responses in mice Science 340 2013 968 971
35. A. Nardi, N. Damann, T. Hertrampf, and A. Kless Advances in targeting voltage-gated sodium channels with small molecules ChemMedChem 7 2012 1712 1740
36. W.M. Pardridge, and R.J. Boado Reengineering biopharmaceuticals for targeted delivery across the blood-brain barrier Methods Enzymol. 503 2012 269 292
37. J. Payandeh, T. Scheuer, N. Zheng, and W.A. Catterall The crystal structure of a voltage-gated sodium channel Nature 475 2011 353 358
38. S.E. Ross, A.R. Mardinly, A.E. McCord, J. Zurawski, S. Cohen, C. Jung, L. Hu, S.I. Mok, A. Shah, and E.M. Savner et al. Loss of inhibitory interneurons in the dorsal spinal cord and elevated itch in Bhlhb5 mutant mice Neuron 65 2010 886 898
39. W.A. Schmalhofer, J. Calhoun, R. Burrows, T. Bailey, M.G. Kohler, A.B. Weinglass, G.J. Kaczorowski, M.L. Garcia, M. Koltzenburg, and B.T. Priest ProTx-II, a selective inhibitor of NaV1.7 sodium channels, blocks action potential propagation in nociceptors Mol. Pharmacol. 74 2008 1476 1484
40. A.M. Scott, J.D. Wolchok, and L.J. Old Antibody therapy of cancer Nat. Rev. Cancer 12 2012 278 287
41. Y.G. Sun, and Z.F. Chen A gastrin-releasing peptide receptor mediates the itch sensation in the spinal cord Nature 448 2007 700 703
42. H. Sun, and M. Li Antibody therapeutics targeting ion channels: are we there yet? Acta Pharmacol. Sin. 34 2013 199 204
43. K.J. Swartz, and R. MacKinnon Hanatoxin modifies the gating of a voltage-dependent K+ channel through multiple binding sites Neuron 18 1997 665 673
44. K.J. Swartz, and R. MacKinnon Mapping the receptor site for hanatoxin, a gating modifier of voltage-dependent K+ channels Neuron 18 1997 675 682
45. A.J. Todd Neuronal circuitry for pain processing in the dorsal horn Nat. Rev. Neurosci. 11 2010 823 836
46. X. Wang, J. Zhang, D. Eberhart, R. Urban, K. Meda, C. Solorzano, H. Yamanaka, D. Rice, and A.I. Basbaum Excitatory superficial dorsal horn interneurons are functionally heterogeneous and required for the full behavioral expression of pain and itch Neuron 78 2013 312 324
47. J. Weiss, M. Pyrski, E. Jacobi, B. Bufe, V. Willnecker, B. Schick, P. Zizzari, S.J. Gossage, C.A. Greer, and T. Leinders-Zufall et al. Loss-of-function mutations in sodium channel Nav1.7 cause anosmia Nature 472 2011 186 190
48. S.Z. Xu, F. Zeng, M. Lei, J. Li, B. Gao, C. Xiong, A. Sivaprasadarao, and D.J. Beech Generation of functional ion-channel tools by E3 targeting Nat. Biotechnol. 23 2005 1289 1293
49. Z.Z. Xu, L. Zhang, T. Liu, J.Y. Park, T. Berta, R. Yang, C.N. Serhan, and R.R. Ji Resolvins RvE1 and RvD1 attenuate inflammatory pain via central and peripheral actions Nat. Med. 16 2010 592 597
50. S. Yang, Y. Xiao, D. Kang, J. Liu, Y. Li, E.A. Undheim, J.K. Klint, M. Rong, R. Lai, and G.F. King Discovery of a selective NaV1.7 inhibitor from centipede venom with analgesic efficacy exceeding morphine in rodent pain models Proc. Natl. Acad. Sci. USA 110 2013 17534 17539
51. T. Zimmer, and R. Surber SCN5A channelopathies - an update on mutations and mechanisms Prog. Biophys. Mol. Biol. 98 2008 120 136
52. W.J. Dixon Efficient analysis of experimental observations Annu. Rev. Pharmacol. Toxicol. 20 1980 441 462
53. C.K. Park, N. Lü, Z.Z. Xu, T. Liu, C.N. Serhan, and R.R. Ji Resolving TRPV1- and TNF-α-mediated spinal cord synaptic plasticity and inflammatory pain with neuroprotectin D1 J. Neurosci. 31 2011 15072 15085
54. R.G. Xie, D.W. Zheng, J.L. Xing, X.J. Zhang, Y. Song, Y.B. Xie, F. Kuang, H. Dong, S.W. You, H. Xu, and S.J. Hu Blockade of persistent sodium currents contributes to the riluzole-induced inhibition of spontaneous activity and oscillations in injured DRG neurons PLoS ONE 6 2011 e18681
55. Z.Q. Zhao, F.Q. Huo, J. Jeffry, L. Hampton, S. Demehri, S. Kim, X.Y. Liu, D.M. Barry, L. Wan, and Z.C. Liu et al. Chronic itch development in sensory neurons requires BRAF signaling pathways J. Clin. Invest. 123 2013 4769 4780